Exscientia has advanced a drug candidate for Alzheimer's disease into human testing ... compulsive disorder billed as the first AI-designed drug to enter the clinic. Exscientia says it is the ...
Study Finds on MSN5d
Researchers uncover serious flaw in promising Alzheimer’s blood testsNew research reveals concerns over the Alzheimer's blood test accuracy, highlighting phosphorylated tau proteins in ALS ...
11d
POTOMAC, MD / ACCESS Newswire / March 4, 2025 / IGC Pharma, Inc. ("IGC" or the "Company") (NYSE American:IGC) today announced ...
A bill calls for the implementation of an Alzheimer’s Disease Awareness Program that would better educate residents on the ...
MINNEAPOLIS — Minnesotans living with Alzheimer’s disease have another option for fighting the most common cause of dementia. More specifically, Leqembi (lecanemab) and Kisunla (donanemab ...
Brain inflammation, while a crucial part of the body's immune response, takes on a detrimental role in Alzheimer's disease. Unlike the acute, short-lived inflammation that combats infection ...
For more than three decades, scientists have been racing to stop Alzheimer's disease by removing amyloid beta plaques - sticky clumps of toxic protein that accumulate in the brain. Now ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback